Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Radiol. Nov 28, 2024; 16(11): 696-699
Published online Nov 28, 2024. doi: 10.4329/wjr.v16.i11.696
Published online Nov 28, 2024. doi: 10.4329/wjr.v16.i11.696
Carbon ion radiation therapy in prostate cancer: The importance of dosage
Teeradon Treechairusame, Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
Pahnwat T Taweesedt, Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, United States
Pahnwat T Taweesedt, Sierra Pacific Mental Illness Research, Education, and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA 94304, United States
Author contributions: Treechairusame T and Taweesedt PT contributed to this paper; Treechairusame T designed the overall concept and outline of the manuscript; Taweesedt T contributed to the discussions; Treechairusame T and Taweesedt PT contributed to the writing, and editing the manuscript, and review of the literature.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Pahnwat T Taweesedt, MD, Instructor, Postdoctoral Fellow, Department of Psychiatry and Behavioral Sciences, Stanford University, No. 401 Quarry Road, Stanford, CA 94305, United States. pahnwatt@stanford.edu
Received: August 9, 2024
Revised: October 11, 2024
Accepted: November 1, 2024
Published online: November 28, 2024
Processing time: 110 Days and 7 Hours
Revised: October 11, 2024
Accepted: November 1, 2024
Published online: November 28, 2024
Processing time: 110 Days and 7 Hours
Core Tip
Core Tip: Carbon ion radiotherapy (CIRT) is widely implemented for many cancer types, including prostate cancer. Gastrointestinal toxicity, particularly rectal bleeding, is a notable risk of radiotherapy. The knowledge of CIRT dosage is crucial as it may impact the risk of rectal bleeding.